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Abstract—Tuberculosis is a multisystem disorder 
characterized by the formation of swelling that is filled with 
blood which is caused from breakage in the wall of a blood vessel. 
This breakage can occur in different organs of the body and is 
caused by a bacterium known as Mycobacterium Tuberculosis 
(mtb) which can be represented as a metabolic network with 
genes, proteins and enzymes that are interconnected. This 
interconnection defines the uniqueness of any bacteria. The 
analysis of a metabolic network system is achievable through 
different computational techniques depending on what 
information is available. The flux balance analysis is mostly used 
for analyzing this type of network because of the little amount of 
information required. The application of flux balance analysis to 
mtb involves the conversion of the metabolic network into a 
stoichiometric matrix where the rows represents the metabolites 
and the columns represent the reactions. In this study, the 
stoichiometric matrix is an 828 by 1027 matrix. The analysis 
generated a linear problem having more unknowns than the 
number of equations. This type of problem is normally solved 
using an extreme pathways algorithm to extract independent 
paths and simplex method for optimization of biomass. Here, the 
extreme pathways analysis was used in the categorization of the 
metabolite of mtb while biomass was employed as the objective 
function using default constraints. The output represents three 
categories of metabolite: 31 metabolites that form part of the 
biomass component that are inactive, 14 metabolites that remain 
active and 32 metabolites that are activated after the 
optimization process.   
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I.  INTRODUCTION  
One of the diseases that has caused a lot of infection and 
have also led to the death of a lot of people is Tuberculosis. 
This disease is caused by Mycobacterium Tuberculosis (mtb). 
Tuberculosis is a multisystem disorder that involves the 
formations of hematomas in multiple organs of the body [1]. In 
order to achieve a successful evaluation of mtb, the extreme 
pathways analysis which is focused on extracting the sets of 
metabolites pathways that are independent must be 
implemented. The output is used for the optimization of the 
biological system using an objective function. Presently, the 
early discovery of this disease and a cure still remain a threat in 
medicine because there is no single symptom that can be used 
to uniquely identify the disease [1]. 
 Most of the cases of mtb aside from the fact that in claims 
the lives of most of its victims, is the difficulty that exist in the 
early diagnosis of this disease. The disease is very difficult to 
diagnose at early stages because the tuberculosis disease has 
the potential to remain in a dormant state without detection. 
Adding to the peculiarity of this disease is the fact that it is not 
hereditary so there is no means of genetically tracing the 
disease. 
Metabolic network analysis carried out in most literatures 
use a part of a metabolic network as a basis to evaluate the 
overall behaviour of the network without putting into 
consideration what other metabolites are affected by that 
section of the network. So in any metabolic network analysis, it 
is important to examine what component of the metabolic 
network is affected by a target before using the target to 
analyze the overall behaviour of the network when such target 
is manipulated. It is this ignored aspect that is the focus of this 
research with application to Mycobacterium Tuberculosis. 
The study therefore applied flux balance analysis to the 
categorization of the metabolites of mtb using biomass. This 
was achieved by the construction of metabolic network for mtb, 
then, the extraction of Stoichiometric matrix for the organism 
and next was the development of a flux balance analysis 
system. Finally, the flux balance analysis was applied to an 
objective function. 
II. RELATED WORKS 
Extreme pathways analysis is an approach that has been 
applied to different organism for prediction purposes. Such as 
to discover if the organism’s predicted computational growth 
rate is similar to the experimental growth rate in the laboratory 
as conducted by [2] where they used the extreme pathways 
approach to measure and predict the secretion rate of 
Escherichia coli using aerobic and anaerobic cells. 
An extreme pathway is also used for predicting drug targets 
for different bacterium. These drugs could serve as a cure for 
those diseases or limit the damage the bacterium causes. Study 
by [3] applied the extreme pathways to predicting possible 
drugs for the treatment of malaria. Apart from drug prediction, 
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the distinct characteristics of an organism can also be derived 
through the extreme pathways [4]. 
Other area of use of extreme pathway analysis is in the area 
of reaction rate [5] and also to investigate the relationship 
between an organism and its environment [6]. 
III. MATERIALS AND METHODS 
A. Metabolic Network Construction 
A metabolic network reconstruction collects all of the 
relevant metabolic information of an organism and compiles it 
in a mathematical model. “Validation and analysis of 
reconstructions can allow identification of key features of 
metabolism such as growth yield, resource distribution, 
network robustness, and gene essentiality” [7]. “The 
Advancement of sequencing technologies and high throughput 
“omics” methods has greatly aided the reconstrution of 
metabolic networks at a genomic scale” [8]. Latest 
development in genome annotations and the progress of omics 
have made it easier to extract metabolism and possible 
information at genomic scale [8]. This has produced great 
efforts in network reconstruction and predictive model 
building. Re-constructions for organisms network has been 
possible with inadequate biochemical data, most of whose 
networks are reconstructed depending on genome annotations 
[8].The model includes the listed information below: 
• The list of all possible enzymes existing in the 
organism of interest 
• The substrates and products of enzymatic reactions 
• The stoichiometric coefficients of each of these 
compounds 
• Information about thermodynamic reversibility or 
irreversibility of each reaction 
• Conditions for the activity or inactivity of each 
enzyme 
• Sub cellular localizations of each enzyme 
 
B. Stoichiometric Matrix 
Stoichiometric matrix is a component of flux balance 
analysis that is used to represent the attributes that makes up a 
metabolic network usually denoted by S. It is an m x n matrix 
in which m (row) represents the individual metabolites 
involved in every reaction that exists in the metabolic network 
why n (column) represent the number reactions involved in the 
metabolic system [9]. Building a stoichiometric matrix from a 
metabolic network follow some standard rules such as; 
• In every reaction that takes place within a metabolic 
network, a metabolite is either produced or 
consumed. 
• In a particular reaction,  
o If a metabolite is produced (gain), the 
coefficient of that metabolite is used to 
represent that metabolite under that reaction. 
o If a metabolite is consumed (loss), the 
coefficient of that metabolite is also used to 
represent that metabolite but with a negative 
sign. 
• If a metabolite does not take part in a particular 
reaction, it is represented with a zero value. 
• If a reaction is bi-directional, it is represented as two 
different reactions in which one is positive while the 
other is negative. 
 
The stoichiometric matrix of any metabolic network 
represents the metabolites involved in a reaction, the status of 
such metabolites in that reaction (loss or gain?) and the 
quantity of the metabolite involved in that reaction. The point 
of interception of the rows and column in the stoichiometric 
matrix indicates the status of every metabolite. It shows if that 
metabolite partakes of a particular reaction, and if it does, the 
sign (+/-) of the value at the point of interception will indicate 
if the metabolite is consumed or produced. The value at the 
point of interception also indicates the quantity of that 
metabolite involved in the reaction [10]. 
C. Flux Balance Analysis Formulation 
      The Impose constraints setting stage is the stage where the 
flux balance analysis is formed. This involves three other 
stage which are: 
Dynamic mass balancing 
Steady state assumption 
Linear problem formulation 
At the dynamic mass balancing stage, the formula: 
dt
dc
vS =.  is applied to the constructed stoichiometric matrix.  
c = concentration 
t = time 
s = stoichiometric matrix 
v = flux vector 
That is, the differentiation of compound concentration over 
time equals the multiplication of stoichiometric matrix and flux 
vector.  
After the mass balancing, the next stage which is the steady 
state assumption is implemented. The steady state assumption 
states that the differentiation of compound concentration over 





Hence the mass balancing in the previous step results to: 
 0. =vS  
That is, the multiplication of the stoichiometric matrix and 
the flux vector results to zero. It is this steady state assumption 
that gives the flux balance analysis method an advantage over 
the other metabolic network analysis techniques. 
The resolving of the steady state equation (S.v = 0) leads to 
the linear problem formulation. It’s a linear problem because 
the numbers of unknowns are more than the number of 
equations. In order to evaluate this steady state equation, an 
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algorithm known as the Extreme pathways algorithm used 
originally by [11] is applied. 
At steady state, there are some groups of reactions 
(pathways) that remain active in the existence of the organism. 
These are referred to as extreme pathways. It is believed that 
pathways, particularly the extreme pathways are what cells aim 
to regulate. Hence, rather than guessing, it is more beneficial to 
understand the regulatory mechanism of these pathways and 
tries to relate it to theoretical pathway structure. These 
pathways are the ultimate objective of cellular regulation. 
The unique extreme pathways can be used to make 
deductions on the functionality in terms of capability and also 
how flux are distributed [11]. Extreme pathways are used to 
analyze an organism metabolic network at steady state. At 
steady state, the metabolic network of an organism which is 
represented by a stoichiometric matrix forms a convex shape 
which results from some pathways that forms the existence of 
that organism. The apex of this convex are referred to as 
extreme pathways. 
The space within these extreme pathways (convex) forms 
the basis of the existence of such organism at steady state. It 
also forms the solution space from where optimization can be 
evaluated [12]. The extreme pathway algorithm involves three 
major categories: the initialization stage, the main calculation 
loop and the balance External Metabolites. 
Initialization Stage: This begins with the appending of an 
nxn  matrix to the transpose of the stoichiometric matrix ST of 
the given metabolic network to form an initial table T. with the 
new matrix T, the external fluxes that are without constraints 
are transferred to a temporary matrix TE.  After enforced this 
separation, the metabolites {M} without an external flux 
connected with it must also be identified. 
Main Calculation loop stage: Here, the extreme pathway 
algorithm tries to balance the fluxes on each of the metabolites. 
This is done through iterations such that the ith iteration copies 
all the rows from Ti-1 that contains a zero in the column of the 
transposed stoichiometric ST.  This column becomes the 
pivoting column. The rows of the column in the pivoting row 
with values of opposite signs are added together to form a new 
matrix Ti  [6]. 
Balance External Metabolite:  This begins by appending the 
TE to the resulting matrix from the previous phase.  From the 
ST matrix, the first non-zero column is added to the 
corresponding row in TE. This is done so as to achieve a zero in 
the non-zero position in the column from ST. When zeros have 
been achieved in the metabolites, the TE can then be removed. 
The resulting matrix T forms the extreme pathways of the 
metabolic network [6]. 
D. Simplex Method 
      The simplex method is an approach to solving a linear 
equation problem such that there is an objective function that 
needs to be optimized using some given constraints. The stages 
involved are: 
Step 1 
All the equations must be standardized by introducing a 
slack variable. For the objective function, this is done by 
making the variable to be optimized the subject of formula. 
Stage 2 
The second stage of the operation of the simplex method is 
a test for negative elements in the bottom row of the matrix. 
The aim of the simplex linear solving problem is to optimize 
by eliminating negative values from the last row of a given 
matrix. If negative value(s) exist, an optimization procedure is 
carried out otherwise; there is already an optimized value for 
the given objective function. 
Stage 3 and 4 
This stage is implemented when there exists a negative 
element in the last row of the given matrix haven appended the 
objective function. At this phase, a pivot column is selected by 
picking the most negative element from the last row of the 
matrix. The column of such element becomes the pivot 
column. 
Stage 5 
The goal of getting a pivot row is to produce a 1 for the 
coefficient above the most negative element that gives the 
smallest quotient after division. This is achieved through the 
use of an elementary row operation. That is dividing the pivot 
row by the number in the position where a 1 in needed. After 
obtaining a 1, there is need to obtain a zero in the other 
positions of the pivot column. This is achieved by subtracting 
multiples of the pivot rows from the other rows. The process 
returns to stage 2 to test for the most negative element in the 
last row then repeat the process till there is no negative element 
in the last row. 
IV. RESULTS AND DISCUSSION 
The optimization approach in this research is the metabolite 
optimization approach where a set of target metabolite 
(biomass) is used as the optimized metabolite to extract 
metabolites that becomes active and inactive at the given 
biomass metabolite. This optimization is confined to the 
solution space formed by the extreme pathways. The biomass 
component of mtb is comprised of 45 metabolites. 
With reference to the biomass metabolites, the set of 
metabolites that are active is extracted using the equation: 
 
Where; 
V = biomass metabolite 
W = activated metabolite (desired output) 
EP = Extreme pathways 
i – k = 1 
w  0 
Using the above equation, the output ‘w’ represents a list of 
metabolites that becomes active when ‘v’ is activated. 
The optimization result is made up of different metabolites 
that are active at the given objective targets. The most 
important aspect of extreme pathway optimization are the 
extractions of metabolites that become activated at the 
,
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optimization phase. Biologically, they represent a further 
reduction in the solution space created by the extreme pathway 
analysis with respect to the objective function. In this research, 
these represent a set of metabolite that is linked with biomass  
TABLE I.  UNIQUELY ACTIVE METABOLITES 
Abbreviation Full Name 
arachACP(c)- eicosanoyl-ACP 





meroacidACP(c)- alpha meroacid ACP 
meroacidcyc1ACP(c)-  cyclopropanated alpha meroacid ACP 
 (1 cyclopropane ring 
mi1p-D(c)- 1D-myo-Inositol 1-phosphate 
mppp9(c)- Magnesium protoporphyrin 
mql6(c)- Menaquinol 6 
mqn6(c)- Menaquinone 6 
mshfald(c)- mycothiol conjugated methanol 
odecoa(c)- Octadecenoyl-CoA  
ohpb(c)- 2-Oxo-3-hydroxy-4-phosphobutanoate 
omdtria(c)- octa-methyl dotriacontanoic acid (C32:0 
with 7 methyl branches) 
palmACP(c)- Palmitoyl-ACP (n-C16:0ACP) 
pan4p(c)- Pantetheine 4'-phosphate 
pant-R(c)- (R)-Pantoate 
pep(c)- Phosphoenolpyruvate 
peptido_TB1(c)- peptidoglycan subunit  
pgp190(c)- Phosphatidylglycerophosphate 
(dituberculostearoyl, C19:0) 
phdca(c)- phenol palmitic acid 
phdcaACP(c)- phenol palmitic acid ACP 
ppp9(c)- Protoporphyrin 
tmhexc(c)- tri-methyl hexacosanoate 
tmlgnc(c)- tri-methyl lignoceric acid 
trdox(c)- Oxidized thioredoxin 







in mtb. That is, production of biomass also links to the 
production of these set of metabolites. Hence to reduce 
metabolite production which is to reduce the growth of the 
bacterium, this group of metabolites should be considered. The 
metabolites produced in this study are listed in Table I with the 
abbreviation and their full name. 
 Table II is a collection of metabolites that are part of the 
biomass component and also remain active as part of the 
component of the extreme pathways. The list of metabolites in 
Table II includes abbreviation and their full name. 
 There are also a group of metabolites that are used as part 
of the objective flux in optimizing the extreme pathways that 
are not present in the output of the optimization result. These 
comprised of some set of metabolites that were active as a part 
of the objective flux but become inactive and as a result are not 
parts of the optimization result. There are 31 of such metabolite 
that became in-active. The metabolites in this category are 
listed in Table III below with their abbreviation and the full 
name. 
TABLE II.  COMMON ACTIVE METABOLITES BETWEEN BIOMASS AND 
ACTIVE FLUX 
Abbreviation Full name 
Ac1PIM1- acyl phosphatidylinositol mannoside 
Ac1PIM2- acyl phosphatidylinositol mannoside di-mannose 
Ac1PIM3- acyl phosphatidylinositol mannoside tri-mannose 
Ac1PIM4- acyl phosphatidylinositol mannoside tetra-mannose 
Ac2PIM2- di-acyl phosphatidylinositol mannoside di-mannose 
PIM1- phosphatidylinositol mannoside 
PIM2- phosphatidylinositol mannoside di-mannose  
PIM3- phosphatidylinositol mannoside tri-mannose  
PIM4- phosphatidylinositol mannoside tetra-mannose  
PIM5- phosphatidylinositol mannosidepenta-mannose  
PIM6- phosphatidylinositol mannosidehexa-mannose  
Arach- Arachidic acid 









TABLE III.  LIST OF DEACTIVATED METABOLITES IN OBJECTIVE FUNCTION 
Abbreviation Full name 
Hexc- hexacosanoate 
Kmycolate- ketomycolate (2 cyclopropanated rings) 
Mbhn- methyl behenic acid 
Mcbts- mycobactin S 
Mfrrppdima- phenolic glycolipid (Mtb) 
Mmmycolate- methoxymycolate (1 cyclopropanated ring) 
Mmycolate- methoxymycolate (2 cyclopropanated rings) 




pa160-1,2- dihexadecanoyl-sn-glycerol 3-phosphate 
pa160190- 1,2-sn-glycerol 3-phosphate 




pg160190- Phosphatidylglycerol (hexadecanoyl, methylstearoyl) 
pg190- Phosphatidylglycerol 






phdca- phenol palmitic acid 
fcmcbtt- iron(III) chelated carboxymycobactin T  
hdca- Hexadecanoate 
clpn160190- cardiolipin (dihexadecanoyl, dimethylstearoyl) 
dhor Dihydroorotate 
arabinanagalfragund- arabinofuranose-galactofuranosyl(30)-rhamanosyl-N-  
arabinan- acetylglucosamyl-undecaprenyl diphosphate 
 
The summary of the observation from this research is 














































Figure. 1: Graphical representation of result summary 
V. CONCLUSION 
     This study has been carried out to investigate the 
capabilities of computational methods and to predict the 
metabolic activities of the mtb. In line with this objective, a 
metabolic network was extracted from various biological 
databases. The extracted metabolic network was represented 
in a stoichiometric matrix. A familiar method to getting an 
understanding into the metabolism of an organism is to 
analyze the network using a computational approach; Extreme 
pathway analysis was used in this work to investigate the 
biomass component of mtb. This was achieved by extracting 
the extreme pathways and then using these pathways to 
evaluate the behaviour of the metabolites in the network at 
certain conditions. The result provided us with information 
listing all the extreme pathways that are active at the given 
biomass component objectives. 
     Tuberculosis is a major infection that has claimed a lot of 
victims. Its peculiarity is in the ability to remain dormant for a 
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long time without being detected. A lot of research is ongoing 
with aims to reduce the impact of this disease on humanity. A 
biological understanding of the nature of the bacteria that 
causes this disease (on which this study is based) will provide 
additional information to help develop cure for the disease. In 
this work, the nature of the cause of tuberculosis in terms of 
pathway analysis has been identified. The results therefore 
help in the analysis of this bacterium in terms of pathway 
redundancy, correlated reaction set and extreme pathway 
reaction participation. 
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